The consumption of bisphosphonates for the treatment and prevention of osteoporosis might not be good for the bones after all. In a recent development it has been found that the drug being used to fight the bone thinning disease osteoporosis might result in the person consuming the drug suffering a fracture.

The advisory was announced by the U. S. Food and Drug Administration on Wednesday, which has stated that the consumption of the drug could increase the risk of the patient suffering a rare fracture of the thigh bone. However, despite this new discovery, earlier research work has found that biphosphonates actually helps in slowing down bone loss and helps in reducing the risk of fractures among people suffering from osteoporosis.

However, the FDA has also stated that the relation between fractures and biphosphonates is still not clear, as there has not been a proper investigation into the development. Still, the FDA has said that the reason behind the warning is due to a number of people suffering from such fractures have reported to been medicated by biphosphonates.

The Deputy Director of the CDC’s Office of New Drugs, Rear Admiral Sandra Kweder while talking about the new development has stated that the FDA has warned, yet again, people about the use of biphosphonates against osteoporosis. The FDA has also asked pharmaceutical Companies to label the pack of the medicines with an advisory.